Page last updated: 2024-08-24

remifentanil and Invasiveness, Neoplasm

remifentanil has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ke, J; Liang, W	1

Other Studies

1 other study(ies) available for remifentanil and Invasiveness, Neoplasm

Article	Year
Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR-650/TIMP3 axis. International journal of experimental pathology, 2022, Volume: 103, Issue:2 Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; Remifentanil; RNA, Long Noncoding; Tissue Inhibitor of Metalloproteinase-3	2022

Article

Year

Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR-650/TIMP3 axis.

International journal of experimental pathology, 2022, Volume: 103, Issue:2

Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; Remifentanil; RNA, Long Noncoding; Tissue Inhibitor of Metalloproteinase-3

2022